Sept 21 (Reuters) - Theradiag SA ALTHE.PA :
* H1 REVENUE 4.9 MILLION EUR VERSUS 5.0 MILLION EUR YEAR AGO
* H1 NET LOSS -229,000 EUR VERSUS 727,000 EUR PROFIT YEAR
AGO
* CONTINUED INVESTMENT IN RESEARCH AND DEVELOPMENT TO DRIVE
FUTURE
GROWTH
* H1 OPERATING LOSS EUR 0.4 MILLION VERSUS LOSS OF EUR 0.2
MILLION
(REPORTED) YEAR AGO
* AT JUNE 30, 2020, NET CASH STOOD AT EUR 1.7 MILLION,
COMPARED TO
EUR 2.9 MILLION AT DECEMBER 31, 2019
* SEES LIKELY IMPACT OF AROUND 10% ON 2020 FULL-YEAR
REVENUE.
* WILL DO ITS UTMOST TO STAY COURSE, MEET ITS FINANCIAL
TARGETS
AND RETURN TO BREAKEVEN OVER A PERIOD EXTENDED UNTIL 2021
Source text for Eikon: ID:nBw2BCwG5a
Further company coverage: ALTHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))